Immunomedics, Inc. (IMMU) Reports Q4 EPS of 3c

August 24, 2011 8:32 AM EDT
Immunomedics, Inc. (NASDAQ: IMMU) reported Q4 EPS of $0.03, $0.09 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $3.43 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings